Pharmacokinetically guided dosing of carboplatin in paediatric cancer patients with bilateral nephrectomy

Cancer Chemotherapy and Pharmacology

Volumn 54, Issue 4, 2004, Pages 295-300

  Veal, Gareth J ^a   English, Martin W ^b   Grundy, Richard G ^b   Shakespeare, Cay ^b   Glaser, Adam ^c   Waters, Fiona ^c   Holden, Vicky ^c   O'Meara, Anne ^d   Michalski, Antony ^e   Howe, Karen ^e   Cole, Sue ^e   Boddy, Alan V ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Bilateral nephrectomy; Carboplatin; Paediatric; Pharmacokinetics

Indexed keywords

CARBOPLATIN;

AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CASE REPORT; CHILDHOOD CANCER; DOSE CALCULATION; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG MONITORING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NEPHROBLASTOMA; PHARMACOKINETICS; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; KIDNEY FUNCTION TESTS; MALE; NEPHRECTOMY; WILMS TUMOR;

EID: 4644222501     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0820-3     Document Type: Article

References (11)

1. English MW, Lowis SP, Peng B, Newell DR, Price L, Pearson ADJ (1996) Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis. Br J Cancer 73:776
2. Gaynon PS (1994) Carboplatin in pediatric malignancies. Semin Oncol 21[Suppl 12]:65
3. Jodrell DI, Egorin MJ, Canetta RM, Langenberg P, Goldbloom EP, Burroughs JN, Goodlow JL, Tan S, Wiltshaw E (1992) Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer. J Clin Oncol 10:520
4. Koren G, Weitzman S, Klein J, Moselhy G (1993) Comparison of carboplatin pharmacokinetics between an anephric child and two children with normal renal function. Med Pediatr Oncol 21:368
5. Kudelka AP, Siddik ZM, Balat O, Kavanagh JJ (1995) Carboplatin dosimetry in renal failure. J Clin Oncol 13:2147
6. Madden T, Sunderland M, Santana VM, Rodman JH (1992) The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer. Clin Pharmacol Ther 51:701
7. Marina NM, Rodman JH, Murry DJ, Sheman SJ, Bowman LC, Jones PP, Furman WL, Meyer WH, Pratt CB (1994) Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in newly diagnosed pediatric solid tumors. J Natl Cancer Inst 86:544
8. Newell DR, Siddik ZH, Gumbrell LA, Boxall FE, Gore ME, Smith IE, Calvert AH (1987) Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin. Eur J Cancer Clin Oncol 23:1399
9. Newell DR, Pearson ADJ, Balmanno K, Price L, Wyllie RA, Keir M, Calvert AH, Lewis IJ, Pinkerton CR, Stevens MC (1993) Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. J Clin Oncol 11:2314
10. Thomas HD, Boddy AV, English MW, Hobson R, Imeson J, Lewis I, Morland B, Pearson ADJ, Pinkerton R, Price L, Stevens M, Newell DR (2000) Prospective validation of renal function-based carboplatin dosing in children with cancer: a United Kingdom Children's Cancer Study Group trial. J Clin Oncol 18:3614
11. Veal GJ, Foot A, McDowell H, Ellershaw C, Pearson ADJ, Boddy AV (2002) Optimization of high dose carboplatin treatment in children with stage IV soft tissue sarcoma (SIOP/UKCCSG MMT 98 study) by real-time pharmacokinetic monitoring. Proc Am Assoc Cancer Res 43:1364